Lose Mazindol 2mg is a tricyclic anorexigenic agent unrelated to and less toxic than amphetamine, but with some similar side effects.
CONTRAINDICATIONS IFA LOSE MAZINDOL 2MG
IFA Lose Mazindol 2mg should not be administered together or for 14 days after the administration of monoamine oxidase inhibitors, as it may result in hypertensive crisis, nor should it be given to patients hypersensitive to amphepramone or idiosyncratic to sympathomimetic amines, agitation or emotionally unstable individuals who are susceptible or with a history of drug or alcohol abuse.
SIDE EFFECTS OF IFA LOSE MAZINDOL 2MG
an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives); an irregular heartbeat or very high blood pressure (severe headache, blurred vision); or hallucinations, abnormal behavior, or confusion.
Other, less serious side effects may be more likely to occur. Continue to take mazindol and talk to your doctor if you experience restlessness or tremor, nervousness or anxiety, headache or dizziness, insomnia, dry mouth or an unpleasant taste in your mouth, diarrhea or constipation, or impotence or changes in your sex drive.
IFA Lose Mazindol 2mg is habit forming. You can become physically and psychologically dependent on this medication, and withdrawal effects may occur if you stop taking it suddenly after several weeks of continuous use.
DOSAGE IFA LOSE MAZINDOL
The administration is oral. The dosage depends on the concentration of the tablet used. Also, in general terms it is suggested not to exceed 2mg per day while obtaining the desired therapeutic effect. The dose should be adjusted according to the response of each patient to a maximum of three tablets of 1 mg / day, one after each meal. A maximum treatment period of between three and six months is recommended